Myriad Genetics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $205,700 | $213,100 | $195,900 | $210,600 |
Gross Profit | 143,800 | 151,800 | 134,200 | 150,900 |
EBITDA | -9,800 | -315,000 | -14,200 | -23,600 |
EBIT | -22,400 | -329,100 | -28,600 | -38,400 |
Net Income | -27,400 | -330,500 | -100 | -42,500 |
Net Change In Cash | 205,700 | 213,100 | 195,900 | 210,600 |
Free Cash Flow | 18,300 | -20,500 | -24,600 | 700 |
Cash | 145,400 | 74,400 | 91,800 | 102,400 |
Basic Shares | 93,100 | 92,500 | 91,400 | 91,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $837,600 | $753,200 | $678,400 | $690,600 |
Gross Profit | 585,400 | 517,000 | 476,400 | 493,000 |
EBITDA | -59,500 | -197,400 | -84,700 | 12,300 |
EBIT | -120,700 | -259,300 | -137,400 | -50,500 |
Net Income | -127,300 | -263,300 | -112,000 | -27,200 |
Net Change In Cash | 837,600 | 753,200 | 678,400 | 690,600 |
Free Cash Flow | -38,400 | -184,200 | -151,600 | 600 |
Cash | 102,400 | 132,100 | 56,900 | 258,400 |
Basic Shares | 90,600 | 82,800 | 80,600 | 78,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.29 |
2025-06-30 | $0.05 |
2025-03-31 | -$0.03 |
